Essential oil of cymbopogon citratus against diabetes: Validation by In vivo experiments and computational studies

Journal of Bioanalysis and Biomedicine

Volumn 5, Issue 5, 2013, Pages 194-203

  Bharti, Sudhanshu Kumar ^a   Kumar, Amit ^b   Prakash, Om ^b   Krishnan, Supriya ^c   Gupta, Ashok Kumar ^a,d  

^a PATNA UNIVERSITY   (India)

^b JAWAHARLAL NEHRU UNIVERSITY   (India)

^c BANARAS HINDU UNIVERSITY   (India)

^d National Institute of Pharmaceutical Education and Research (NIPER)   (India)

Author keywords

Antidiabetic; Cymbopogon citratus; Docking; DPP IV; GCMS; PPAR ; PTP 1B

Indexed keywords

ALPHA ELEMOL; ANTIDIABETIC AGENT; BETA CITRAL; BETA EUDESMOL; BIOLOGICAL MARKER; CITRAL; DIPEPTIDYL PEPTIDASE IV; ESSENTIAL OIL; GERANIOL; GLUCAGON LIKE PEPTIDE 1; LINALOOL; MYRCENE; MYRCENOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT MEDICINAL PRODUCT; PROTEIN TYROSINE PHOSPHATASE 1B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BIOCHEMICAL COMPOSITION; CELL COUNT; CONTROLLED STUDY; CYMBOPOGON CITRATUS; DRUG EFFECT; DRUG SAFETY; HISTOPATHOLOGY; IN VIVO STUDY; INSULITIS; LEAF SHEATH; MALE; MASS FRAGMENTOGRAPHY; MOLECULAR DOCKING; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN CONTENT; RAT; TOXICITY TESTING; VALIDATION STUDY;

EID: 84896722693     PISSN: None     EISSN: 1948593X     Source Type: Journal    
DOI: 10.4172/1948-593X.1000098     Document Type: Article

References (38)

1. Nyenwe EA, Jerkins TW, Umpierrez GE, Kitabchi AE (2011) Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism 60: 1-23.
2. Rosen CJ (2010) Revisiting the rosiglitazone story-lessons learned. N Engl J Med 363: 803-806.
3. Qi LW, Liu EH, Chu C, Peng YB, Cai HX, et al. (2010) Anti-diabetic agents from natural products-an update from 2004 to 2009. Curr Top Med Chem 10: 434-457.
4. Bharti SK, Krishnan S, Kumar A, Rajak KK, Murari K, et al. (2013) Antidiabetic activity and molecular docking of fructooligosaccharides produced by Aureobasidium pullulans in poloxamer-407-induced T2DM rats. Food Chem 136: 813-821.
5. Bharti SK, Krishnan S, Kumar A, Rajak KK, Murari K, et al. (2012) Antihyperglycemic activity with DPP-IV inhibition of alkaloids from seed extract of Castanospermum australe: Investigation by experimental validation and molecular docking. Phytomedicine 20: 24-31.
6. Combs AP (2010) Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer. J Med Chem 53: 2333-2344.
7. Hontecillas R, O'Shea M, Einerhand A, Diguardo M, Bassaganya-Riera J (2009) Activation of PPAR gamma and alpha by punicic acid ameliorates glucose tolerance and suppresses obesity-related inflammation. J Am Coll Nutr 28: 184-195.
8. Waku T, Shiraki T, Oyama T, Maebara K, Nakamori R, et al. (2010) The nuclear receptor PPARγ individually responds to serotonin- and fatty acid-metabolites. EMBO J 29: 3395-3407.
9. Al-masri IM, Mohammad MK, Tahaa MO (2009) Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine. J Enzyme Inhib Med Chem 24: 1061-1066.
10. Sutton JM, Clark DE, Dunsdon SJ, Fenton G, Fillmore A, et al. (2012) Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes. Bioorg Med Chem Lett 22: 1464-1468.
11. Sacchetti G, Maietti S, Muzzoli M, Scaglianti M, Manfredini S, et al. (2005) Comparative evaluation of 11 essential oils of different origin as functional antioxidants, antiradicals and antimicrobials in foods. Food Chemistry 91: 621-632.
12. Jeong MR, Park PB, Kim DH, Jang YS, Jeong HS, et al. (2009) Essential oil prepared from Cymbopogon citratus exerted an antimicrobial activity against plant pathogenic and medical microorganisms. Mycobiology 37: 48-52.
13. Hanisa H, Hadijah H, Rasedee A, Tarmizi AS (2011) Sub-acute oral administration of Cymbopogon citratus stem infusion and its effects on blood biochemical parameters, body and organ weights in rats. J Trop Agric and Fd Sc 39: 1-7.
14. Hedges LJ, Lister CE (2006) Nutritional attributes of Brassica vegetables. Crop & Food Research Confidential report no. 1618. New Zeal Inst Crop & Food Res Ltd 46.
15. Puatanachokchai R, Kishida H, Denda A, Murata N, Konishi Y, et al. (2002) Inhibitory effects of lemon grass (Cymbopogon citratus, Stapf) extract on the early phase of hepatocarcinogenesis after initiation with diethylnitrosamine in male Fischer 344 rats. Cancer Lett 183: 9-15.
16. Wasan KM, Subramanian R, Kwong M, Goldberg IJ, Wright T, et al. (2003) Poloxamer 407-mediated alterations in the activities of enzymes regulating lipid metabolism in rats. J Pharm Pharm Sci 6:189-197.
17. McGann M (2012) FRED and HYBRID docking performance on standardized datasets. J Comput Aided Mol Des 26: 897-906.
18. McGann M (2011) FRED pose prediction and virtual screening accuracy. J Chem Inf Model 51: 578-596.
19. Mirghani MES, Liyana Y, Parveen J (2012) Bioactivity analysis of lemongrass (Cymbopogan citratus) essential oil. International Food Research Journal 19: 569-575.
20. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, et al. (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23: 57-63.
21. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
22. Prabhakar KR, Veerapur VP, Parihar KV, Priyadarsini KI, Rao BS, et al. (2006) Evaluation and optimization of radioprotective activity of Coronopus didymus Linn. in gamma-irradiated mice. Int J Rad Biol 82: 525-536.
23. Gelvan D, Saltman P (1990) Different cellular targets for Cu- and Fe-catalyzed oxidation observed using a Cu-compatible thiobarbituric acid assay. Biochim Biophys Acta 1035: 353-360.
24. Bolton EE, Wang Y, Thiessen PA, Bryant SH (2008) Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities. Annual Reports in Computational Chemistry 4: 217-241.
25. Halgren TA (1996) Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. Journal of Computational Chemistry 17: 490-519.
26. Kim D, Wang L, Beconi M, Eiermann GJ, Fisher MH, et al. (2005) (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J Med Chem 13 48:141-151.
27. Mahindroo N, Peng Y H, Lin CH, Tan UK, Prakash E, et al. (2006) Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists. J Med Chem 49: 6421-6424.
28. Wiesmann C, Barr KJ, Kung J, Zhu J, Erlanson DA, et al. (2004) Allosteric inhibition of protein tyrosine phosphatase 1B. Nat Struct Mol Biol 11: 730-737.
29. Stierand K, Rarey M (2010) PoseView-molecular interaction patterns at a glance. J Cheminform 2: 50.
30. Johnston TP, Goldberg IJ (2006) Inhibition of pancreatic lipase by poloxamer may provide an adjunct treatment strategy for weight loss. J Pharm Pharmacol 58: 1099-1105.
31. Modak T, Mukhopadhaya A (2011) Effects of citral, a naturally occurring antiadipogenic molecule, on an energy-intense diet model of obesity. Indian J Pharmacol 43: 300-305.
32. Fernandes C, De Souza H, De Oliveria G, Costa J, Kerntopf M, et al. (2012) Investigation of the mechanisms underlying the gastroprotective effect of Cymbopogon citratus essential oil. J Young Pharm 4: 28-32.
33. Kielgast U, Holst JJ, Madsbad S (2011) Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual β-cell function. Diabetes 60: 1599-1607.
34. Bonner-Weir S (2000) Islet growth and development in the adult. J Mol Endocrinol 24: 297-302.
35. Huynh K PH, Maridable J, Gaspillo P, Hasika M, Malaluan R, et al. (2008) Essential Oil from Lemongrass Extracted by Supercritical Carbon Dioxide and Steam Distillation. The Philippine Agricultural Scientist 91: 36-41.
36. Wagner H, Ulrich-Merzenich G (2009) Synergy research: Approaching a new generation of phytopharmaceuticals. Phytomedicine 16: 97-110.
37. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, et al. (1998) Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395: 137-143.
38. Oberfield JL, Collins JL, Holmes CP, Goreham DM, Cooper JP, et al. (1999) A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation. Proc Natl Acad Sci USA 96: 6102-6106.